Noninvasive genetic testing for type IV collagen nephropathy using oral mucosa DNA sampling in children with haematuria
- PMID: 39540369
- PMCID: PMC11565656
- DOI: 10.1080/0886022X.2024.2423845
Noninvasive genetic testing for type IV collagen nephropathy using oral mucosa DNA sampling in children with haematuria
Abstract
Objective: Hematuria is one of the most common conditions in children, and increase the risk of chronic kidney disease. Persistent hematuria may be the earliest manifestation of type IV collagen-related nephropathy. Early diagnosis is essential for optimized therapy. Due to the invasive nature of kidney biopsy and the high cost of whole exome sequencing, its application in the diagnosis of isolated hematuria is rare. Hence, we performed noninvasive and convenient genetic testing approaches for type IV collagen-related nephropathy.
Methods: We used noninvasive oral mucosa sampling as an alternative method for DNA isolation for genetic testing and designed a panel targeting three type IV collagen nephropathy-related genes in children with hematuria. Children with persistent hematuria unaccompanied by clinically significant proteinuria or renal insufficiency who underwent genetic testing using a hematuria panel were enrolled.
Results: Thirty-seven of 112 (33.0%) patients were found to have a genetic variant in COL4A3/A4/A5. Pathogenic/likely pathogenic COL4A3/A4/A5 variants were identified in 17 of the 112 patients analyzed (15.2%), which were considered to explain their hematuria manifestations. In addition, variants of unknown significance (VUSs) were found in 17.8% (20/112) of patients. Furthermore, we observed a much greater COL4A3/A4/A5 variant detection rate in patients with a positive family history or more severe hematuria (RBC ≥ 20/HP) or with coexisting microalbuminuria (59.2% vs. 12.7%, p < 0.001; 64.0% vs. 24.1%, p < 0.001; 66.7% vs. 30.1%, p = 0.025).
Conclusions: We present the high prevalence of variants in COL4A genes in a multicenter pediatric cohort with hematuria, which requires close monitoring and long-term follow-up.
Keywords: Hematuria; genetic testing; pediatric; type IV collagen-related nephropathy.
Conflict of interest statement
The authors report there are no competing interests to declare.
Figures
Similar articles
-
Variants in genes coding for collagen type IV α-chains are frequent causes of persistent, isolated hematuria during childhood.Pediatr Nephrol. 2023 Mar;38(3):687-695. doi: 10.1007/s00467-022-05627-w. Epub 2022 Jun 27. Pediatr Nephrol. 2023. PMID: 35759000
-
Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.Nephrology (Carlton). 2018 Oct;23(10):940-947. doi: 10.1111/nep.13115. Nephrology (Carlton). 2018. PMID: 28704582 Free PMC article.
-
[Clinical and genetic features of persistent asymptomatic microscopic hematuria in children].Zhonghua Er Ke Za Zhi. 2025 Feb 2;63(2):180-184. doi: 10.3760/cma.j.cn112140-20240812-00572. Zhonghua Er Ke Za Zhi. 2025. PMID: 39844494 Chinese.
-
Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice.Genes (Basel). 2023 Aug 25;14(9):1686. doi: 10.3390/genes14091686. Genes (Basel). 2023. PMID: 37761826 Free PMC article. Review.
-
Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.Pediatr Nephrol. 2020 Jan;35(1):59-66. doi: 10.1007/s00467-018-4121-1. Epub 2018 Nov 30. Pediatr Nephrol. 2020. PMID: 30506145 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous